DK517787A - Lymphokinbeslaegtede peptider - Google Patents

Lymphokinbeslaegtede peptider

Info

Publication number
DK517787A
DK517787A DK517787A DK517787A DK517787A DK 517787 A DK517787 A DK 517787A DK 517787 A DK517787 A DK 517787A DK 517787 A DK517787 A DK 517787A DK 517787 A DK517787 A DK 517787A
Authority
DK
Denmark
Prior art keywords
lymphocyte
related peptides
peptides
Prior art date
Application number
DK517787A
Other languages
English (en)
Other versions
DK517787D0 (da
Inventor
Karel Gerrit Odink
Roger Clerc
Nico Cerletti
Josef Brueggen
Lajos Tarcsay
Clemens Sorg
Walter Wiesendanger
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868623850A external-priority patent/GB8623850D0/en
Priority claimed from GB868628358A external-priority patent/GB8628358D0/en
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK517787D0 publication Critical patent/DK517787D0/da
Publication of DK517787A publication Critical patent/DK517787A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/001—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination
    • C12N2830/002—Vector systems having a special element relevant for transcription controllable enhancer/promoter combination inducible enhancer/promoter combination, e.g. hypoxia, iron, transcription factor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/55—Vector systems having a special element relevant for transcription from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/70—Vector systems having a special element relevant for transcription from fungi
    • C12N2830/702—Vector systems having a special element relevant for transcription from fungi yeast

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK517787A 1986-10-03 1987-10-02 Lymphokinbeslaegtede peptider DK517787A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868623850A GB8623850D0 (en) 1986-10-03 1986-10-03 Lymphokine related peptide
GB868628358A GB8628358D0 (en) 1986-11-27 1986-11-27 Lymphokine related peptides

Publications (2)

Publication Number Publication Date
DK517787D0 DK517787D0 (da) 1987-10-02
DK517787A true DK517787A (da) 1988-04-04

Family

ID=26291377

Family Applications (1)

Application Number Title Priority Date Filing Date
DK517787A DK517787A (da) 1986-10-03 1987-10-02 Lymphokinbeslaegtede peptider

Country Status (11)

Country Link
US (2) US5350687A (da)
EP (1) EP0263072B1 (da)
JP (1) JPH09188698A (da)
AU (1) AU7930987A (da)
DE (1) DE3789413T2 (da)
DK (1) DK517787A (da)
ES (1) ES2052602T3 (da)
FI (1) FI874287A (da)
IE (1) IE61773B1 (da)
NO (1) NO874159L (da)
PT (1) PT85849B (da)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2750604B1 (fr) * 1996-07-02 2002-09-20 Oreal Heteromere liant l'acide arachidonique et son utilisation en cosmetique ou pharmacie
CA2050332A1 (en) * 1989-03-17 1990-09-18 Steven C. Clark Human macrophage migration inhibitory factor
GB8915414D0 (en) * 1989-07-05 1989-08-23 Ciba Geigy Novel cytokines
JP2747839B2 (ja) * 1989-08-14 1998-05-06 花王株式会社 モノクローナル抗体
US5149544A (en) * 1989-11-13 1992-09-22 Research Corporation Technologies, Inc. Method of inhibiting progenitor cell proliferation
WO1992004376A1 (en) * 1990-09-05 1992-03-19 The Heart Research Institute Limited Novel chemotactic factor
CH685959A5 (de) * 1992-08-24 1995-11-15 Biomedicals Ag Diagnostische Testpackung zur Bestimmung von Proteinen.
US6645493B1 (en) * 1993-05-17 2003-11-11 The Picower Institute For Medical Research Composition containing anti-MIF antibody
US5776348A (en) * 1995-02-07 1998-07-07 Massachusetts Institute Of Technology Mineral precipitation system and method for inhibiting mineral precipitate formation
WO1998031799A2 (en) 1997-01-21 1998-07-23 Human Genome Sciences, Inc. Polynucleotides and polypeptides encoding receptors
EP1118681A1 (en) 1998-09-29 2001-07-25 Asahi Kasei Kabushiki Kaisha Method for controlling the release of granules
EP1125134B1 (en) * 1998-11-05 2009-11-04 The Regents Of The University Of Michigan S100 proteins and autoantibodies as serum markers for cancer
MY140679A (en) 2001-05-24 2010-01-15 Avanir Pharmaceuticals Inhibitors of macrohage migration inhibitory factor and methods for identifying the same
WO2003069349A2 (en) * 2002-02-15 2003-08-21 Clemens Sorg Method for diagnosis of inflammatory diseases using mrp8/mrp14
EP1519749B1 (en) 2002-07-05 2009-04-08 Universite Laval Chemotactic factor inhibitor for inhibiting inflammatory reactions
TW200418829A (en) * 2003-02-14 2004-10-01 Avanir Pharmaceutics Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
US7361474B2 (en) * 2003-02-24 2008-04-22 United States Of America As Represented By The Department Of Veterans Affairs Serum macrophage migration inhibitory factor (MIF) as marker for prostate cancer
DE602004017148D1 (de) 2003-03-28 2008-11-27 Univ Laval S100 protein als aktivator neutrophiler zellen zur verminderung der neutropenie bei der krebsbehandlung
BRPI0413695A (pt) * 2003-08-22 2006-10-24 Avanir Pharmaceuticals derivados de naftiridina substituìda como inibidores do fator inibidor da migração de macrófagos e seu uso no tratamento de doenças humanas
AU2005216236A1 (en) * 2004-02-25 2005-09-09 The United States Of America As Represented By The Department Of Veterans Affairs Methods for diagnosing and treating bladder cancer
SE0400886D0 (sv) * 2004-04-02 2004-04-02 Amersham Biosciences Ab Process of purification
CA2573596A1 (en) * 2004-07-13 2006-01-19 Universite Laval S100 protein inhibitors for treating leukemia
US7659087B2 (en) * 2004-07-23 2010-02-09 Aspenbio Pharma, Inc. Methods and devices for diagnosis of appendicitis
DE602005025775D1 (de) 2004-07-23 2011-02-17 Aspenbio Pharma Inc Verfahren und vorrichtungen zur diagnose von appendizitis
EP1861407A1 (en) * 2005-03-24 2007-12-05 Avanir Pharmaceuticals Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors
GB0605689D0 (en) * 2006-03-21 2006-05-03 Novartis Ag Organic compounds
WO2010026450A1 (en) * 2008-09-03 2010-03-11 Quantumdx Group Limited Sensing strategies and methods for nucleic acid detection using biosensors
CN107300496B (zh) 2011-05-20 2020-11-24 国立研究开发法人理化学研究所 生物材料用透明化试剂、及其利用
AU2012320597C1 (en) 2011-10-07 2015-10-15 Baxalta GmbH oxMIF as a diagnostic marker
EP3183581A1 (en) * 2014-08-22 2017-06-28 Baxalta GmbH Detection of cho-mif contaminations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE230876C (da) *
US4322274A (en) * 1980-08-28 1982-03-30 Wilson Gregory B Method of diagnosing cystic fibrosis patients and asymptomatic carrier of the cystic fibrosis gene
GB2125047B (en) 1982-08-09 1986-02-19 Ciba Geigy Ag Yeast hybrid vectors and their use for the production of polypeptides
GB8318754D0 (en) * 1983-07-11 1983-08-10 Fagerhol M K F Human proteins anti-sera test kits
JPS6041697A (ja) * 1983-08-15 1985-03-05 Asahi Chem Ind Co Ltd 活性蛋白質誘導体の新規合成法
CA1297437C (en) 1983-11-21 1992-03-17 Hans Rink Process for the preparation of protease inhibitors
EP0143081B1 (en) 1983-11-21 1989-08-23 Ciba-Geigy Ag Synthesis of tissue plasminogen activator(tpa) by yeast
JPH0672158B2 (ja) 1984-05-24 1994-09-14 チバ−ガイギ− アクチエンゲゼルシヤフト 精製されたヒトマクロファージ遊走阻止因子
GB8915414D0 (en) * 1989-07-05 1989-08-23 Ciba Geigy Novel cytokines

Also Published As

Publication number Publication date
FI874287A (fi) 1988-04-04
DE3789413D1 (de) 1994-04-28
FI874287A0 (fi) 1987-09-30
JPH09188698A (ja) 1997-07-22
DE3789413T2 (de) 1994-07-28
EP0263072A3 (en) 1990-01-10
US5350687A (en) 1994-09-27
EP0263072A2 (en) 1988-04-06
IE61773B1 (en) 1994-11-30
NO874159L (no) 1988-04-05
AU7930987A (en) 1988-05-19
EP0263072B1 (en) 1994-03-23
ES2052602T3 (es) 1994-07-16
DK517787D0 (da) 1987-10-02
PT85849B (pt) 1990-07-31
US5702920A (en) 1997-12-30
NO874159D0 (no) 1987-10-02
IE872645L (en) 1988-04-03
PT85849A (en) 1987-11-01

Similar Documents

Publication Publication Date Title
DK517787A (da) Lymphokinbeslaegtede peptider
DK97790A (da) Renin-inhiberende peptider
DK628687A (da) Vasopressinantagonister
DK111489D0 (da) Peptider
DK510587D0 (da) Vasopressinantagonister
DK353788D0 (da) Polypeptidderivater
DK174388D0 (da) Cycliske peptider
DK551287D0 (da) Polypeptid
DK354487D0 (da) Oncogen-relaterede peptider
DK531986D0 (da) Peptider
DK290588A (da) Renin-inhiberebde peptid
DK253087D0 (da) Syntetiske natriuretiske peptider
DK691787D0 (da) Glycosylerede glycopeptider
DK345087D0 (da) Protein
MC1830A1 (fr) Peptides
DK91586D0 (da) Peptider
DK91686D0 (da) Peptider
DK376187D0 (da) Peptider
DK434986D0 (da) Peptider
DK435086D0 (da) Peptider
DK101587D0 (da) Peptider
DK596888D0 (da) Rekombinant lymfotoksin
DK395685D0 (da) Peptider
DK411686D0 (da) Peptider
DK467785D0 (da) Peptider

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment